A Simple and Specific Stability-Indicating RP-HPLC Method for Routine Assay of Adefovir Dipivoxil in Bulk and Tablet Dosage Form

被引:0
作者
Darsazan, Bahar [1 ,3 ]
Shafaati, Alireza [2 ]
Mortazavi, Seyed Alireza [1 ]
Zarghi, Afshin [2 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmaceut, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmaceut Chem, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Sch Pharm, Students Res Comm, Tehran, Iran
来源
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH | 2017年 / 16卷 / 01期
关键词
Adefovir Dipivoxil; Assay; RP-HPLC; Stability-Indicating; Pharmaceutical dosage form;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A simple and reliable stability-indicating RP-HPLC method was developed and validated for analysis of adefovir dipivoxil (ADV). The chromatographic separation was performed on a C18 column using a mixture of acetonitrile-citrate buffer (10 mM at pH 5.2) 36: 64 (% v/v) as mobile phase, at a flow rate of 1.5 mL/min. Detection was carried out at 260 nm and a sharp peak was obtained for ADV at a retention time of 5.8 +/- 0.01 min. No interferences were observed from its stress degradation products. The method was validated according to the international guidelines. Linear regression analysis of data for the calibration plot showed a linear relationship between peak area and concentration over the range of 0.5-16 mu g/mL; the regression coefficient was 0.9999and the linear regression equation was y = 24844x-2941.3. The detection (LOD) and quantification (LOQ) limits were 0.12 and 0.35 mu g/mL, respectively. The results proved the method was fast (analysis time less than 7 min), precise, reproducible, and accurate for analysis of ADV over a wide range of concentration. The proposed specific method was used for routine quantification of ADV in pharmaceutical bulk and a tablet dosage form.
引用
收藏
页码:132 / 139
页数:8
相关论文
共 13 条
[1]   Development and Validation of RP-HPLC Method for the Determination of Adefovir Dipivoxil in Bulk and in Pharmaceutical Formulation [J].
Ahmed, Zaheer ;
Gopinath, B. ;
Shetty, A. Sathish Kumar ;
Sridhar, B. K. .
E-JOURNAL OF CHEMISTRY, 2009, 6 (02) :469-474
[2]  
Bhirud CH, 2013, INT J PHARM PHARM SC, V5, P844
[3]  
Brayfield Alison, 2014, MARTINDALE COMPLETE, P967
[4]  
Ghari T, 2013, IRAN J PHARM RES, V12, P55
[5]   Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B [J].
Hadziyannis, SJ ;
Tassopoulos, NC ;
Heathcote, EJ ;
Chang, TT ;
Kitis, G ;
Rizzetto, M ;
Marcellin, P ;
Lim, SG ;
Goodman, Z ;
Wulfsohn, MS ;
Xiong, S ;
Fry, J ;
Brosgart, CL .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (09) :800-807
[6]  
International Conference on Harmonization (ICH), 2005, ICH HARM TRIP GUID T
[7]  
[蒋晔 Jiang Ye], 2004, [色谱, Chinese Journal of Chromatography], V22, P248
[8]   Perspectives on the development of acyclic nucleotide analogs as antiviral drugs [J].
Lee, William A. ;
Martin, John C. .
ANTIVIRAL RESEARCH, 2006, 71 (2-3) :254-259
[9]  
Nalbalwar N, 2015, INT J PHARM IN PRESS, P7
[10]  
ONeil MJ., 2006, MERCK INDEX ENCY CHE, V14th, P153